4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene and cyclopentane

4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene has been researched along with cyclopentane in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hirao-Suzuki, M; Nagase, K; Shigemori, E; Suemori, T; Sugihara, N; Takeda, S; Takiguchi, M; Tanaka, M; Tsutsumi, K; Yoshihara, S	1

Other Studies

1 other study(ies) available for 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene and cyclopentane

Article	Year
4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) Targets Estrogen Receptor β, to Evoke the Resistance of Human Breast Cancer MCF-7 Cells to G-1, an Agonist for G Protein-Coupled Estrogen Receptor 1. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Proliferation; Cyclopentanes; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Estrogen Receptor beta; Female; Humans; MCF-7 Cells; Phenols; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction	2021

Article

Year

4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) Targets Estrogen Receptor β, to Evoke the Resistance of Human Breast Cancer MCF-7 Cells to G-1, an Agonist for G Protein-Coupled Estrogen Receptor 1.

Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:10

Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Proliferation; Cyclopentanes; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Estrogen Receptor beta; Female; Humans; MCF-7 Cells; Phenols; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction

2021